Insight into the origin and clonal history of B-cell tumors as revealed by analysis of Immunoglobulin variable region genes

Immunological Reviews

Volumn 162, Issue , 1998, Pages 247-259

  Stevenson, Freda ^a   Sahota, Surinder ^a   Zhu, Delin ^a   Ottensmeier, Christian ^a   Chapman, Caroline ^a   Oscier, David ^b   Hamblin, Terry ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO ACID SEQUENCE; APOPTOSIS; B CELL LYMPHOMA; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL DIFFERENTIATION; CELL POPULATION; CELL TRANSFORMATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; GENE SWITCHING; GENETIC RECOMBINATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; MANTLE CELL LYMPHOMA; PLASMACYTOMA; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, B-CELL; LYMPHOMA, B-CELL; MOLECULAR SEQUENCE DATA; MUTATION;

EID: 0031942845     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01446.x     Document Type: Review

References (101)

1. Rabbitts TH. Chromosomal translocations in human cancer. Nature 1994;372:143-149.
2. Steele EJ, ed. Somatic hypermutation in V-regions. Boca Raton (FL): CRC Press; 1991.
3. Yélamos J, et al. Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature 1995;376:225-229.
4. H repertoire. Immunol Today 1995;16:237-242.
5. Matsuda F, et al. Structure and physical map of 64 variable segments of the 3′ 0.8-megabase region of the human immunoglobulin heavy-chain locus. Nat Genet 1993;3:88-94.
6. Schäble KF, Zachau H-G. The variable genes of the human immunoglobulin κ locus. Biol Chem Hoppe Seyler 1993;374:1001-1022.
7. Williams SC, Frippiat J-P, Tomlinson IM, Ignatovich O, Lefranc M-P, Winter G. Sequence and evolution of the human germline Vλ repertoire. J Mol Biol 1996;264:220-232.
8. H gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5+/IgM+ and CD5-/IgM+ B cells. J Clin Invest 1997;99:2488-2501.
9. H framework region I and complementarity determining region 3. J Mol Biol 1996;256:577-589.
10. Silverman GJ. Human antibody responses to bacterial antigens: studies of a model conventional antigen and a proposed model B cell superantigen. Int Rev Immunol 1992;9:57-78.
11. Levy R, et al. Somatic mutation in human B-cell tumors. Immunol Rev 1987;96:43-57.
12. Bahler DW, Levy R. Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc Natl Acad Sci USA 1992;89:6770-6774.
13. Zelenetz AD, Chen TT, Levy R. Histologic transformation of follicular lymphoma to diffuse lymphoma represents tumor progression by a single malignant B cell. J Exp Med 1991;173:197-207.
14. Zhu D, Hawkins RE, Hamblin TJ, Stevenson FK. Clonal history of a human follicular lymphoma as revealed in the immunoglobulin variable region genes. Br J Haematol 1994;86:505-512.
15. Lam K-P, Kühn R, Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1997;90:1073-1083.
16. Kanzler H, Küppers R, Hansmann M-L, Rajewsky K, Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996;184:1495-1505.
17. Hummel M, Marafioti T, Stein H. Immunoglobulin V genes in Reed-Sternberg cells. N Engl J Med 1996;334:405-406.
18. Efremov DG, Ivanovski M, Batista FD, Pozzato G, Burrone OR. IgM-producing chronic lymphocytic leukaemia cells undergo immunoglobulin isotype-switching without acquiring somatic mutations. J Clin Invest 1996;98:290-298.
19. Malisan F, Fluckiger AC, Ho S, Guret C, Banchereau J, Martinez Valdez H. B-chronic lymphocytic leukemias can undergo isotype switching in vivo and can be induced to differentiate and switch in vitro. Blood 1996;87:717-724.
20. Berek C. The development of B cells and the B-cell repertoire in the micro environment of the germinal center. Immunol Rev 1992;126:5-19.
21. Kelsoe G. In situ studies of the germinal center reaction. Adv Immunol 1995;60:267-288.
22. Chu YW, et al. Somatic mutation of human immunoglobulin V genes in the X-linked hyper IgM syndrome. J Clin Invest 1995;95:1389-1393.
23. Razanajaona D, et al. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome. J Immunol 1996;157:1492-1498.
24. Kosco MH, Pflugfelder E, Gray D. Follicular dendritic cell-dependent adhesion and proliferation of B cells in vitro. J Immunol 1992;148:2331-2339.
25. Oprea M, Perelson AS. Somatic mutation leads to efficient affinity maturation when centrocytes recycle back to centroblasts. J Immunol 1997;158:5155-5162.
26. Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan ICM. Mechanisms of antigen-driven selection in germinal centres. Nature 1989;342:929-931.
27. Klein U, Küppers R, Rajewsky K. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood 1997;89:1288-1298.
28. Dunn-Walters DK, Isaacson PG, Spencer J. Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J Exp Med 1995;182:559-566.
29. Chan JKC, et al. A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group - a summary version. Am J Clin Pathol 1995;103:539-540.
30. H genes are inherently susceptible to amino acid replacement. Immunol Today 1994;15:367-373.
31. Kirkham PM, Schroeder HW Jr. Antibody structure and the evolution of immunoglobulin V gene segments. Semin Immunol 1994;6:347-360.
32. Corbett SJ, Tomlinson IM, Sonnhammer ELL, Buck D, Winter G. Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. J Mol Biol 1997;270:587-597.
33. Betz AG, Neuberger MS, Milstein C. Discriminating intrinsic and antigen-selected mutational hot-spots in immunoglobulin V-genes. Immunol Today 1993;14:405-411.
34. H4-21) gene in human tonsil reveals clonal isotype switch events and a highly variable degree of somatic hypermutation. Clin Exp Immunol 1996;105:360-368.
35. Pascual V, Liu YJ, Magalski A, de Bouteiller O, Bauchereau J, Capra JD. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med 1994;180:29-39.
36. Küppers R, Zhao M, Hansmann M-L, Rajewsky K. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J 1993;12:4955-4967.
37. H5 transcripts from three unrelated patients with atopic dermatitis. J Exp Med 1993;177:99-107.
38. H5 gene segments of a patient with asthma: implications for IgE. Eur J Immunol 1997;27:162-170.
39. Maizels N, Bothwell A. The T cell independent immune response to the hapten NP uses a large repertoire of heavy chain genes. Cell 1985;43:715-720.
40. Wysocki L, Manser T, Gefter ML. Somatic evolution of variable region structures during an immune response. Proc Natl Acad Sci USA 1986;83:1847-1851.
41. Varade WS, Insel RA. Isolation of germinal center-like events from human spleen RNA. J Clin Invest 1993;91:1838-1842.
42. van Es JH, Gmelig Meyling FHJ, Logtenberg T. High frequency of somatically mutated IgM molecules in the human adult blood B cell repertoire. Eur J Immunol 1992;22:2761-2764.
43. Huang C, Steward AK, Schwartz RS, Stollar BD. Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes. J Clin Invest 1992;89:1331-1343.
44. Reynaud CA, Garcia C, Hein WR, Weill J-C. Hypermutation generating the sheep immunoglobulin repertoire is an antigen-independent process. Cell 1995;80:115-125.
45. Kitchingman GR, et al. Biologic and prognostic significance of more than two μ heavy-chain genes in childhood acute lymphobastic leukemia of B precursor origin. Blood 1986;67:698-703.
46. Beishuizen A, Verhoeven M-A J, Hählen K, van Wering ER, van Dongen JJM. Differences in immunoglobulin heavy chain gene rearrangement patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leukemia and diagnosis. Leukemia 1992;6:60-63.
47. Height SE, Swansbury GJ, Matutes E, Treleaven JG, Catovsky D, Dyer MJS. Analysis of clonal rearrangements of the Ig heavy chain locus in acute leukemia. Blood 1996;87:5242-5250.
48. Schroeder HW Jr, Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 1994;15:288-294.
49. H gene expression in CD5+ and CD5- B-cell chronic lymphocytic leukemia. Blood 1995;86:3883-3890.
50. H genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood 1997;89:4153-4160.
51. Matolcsy A, Casali P, Nádor R, Liu Y-F, Knowles DM. Molecular characterization of IgA - and/or IgG - switched chronic lymphocytic leukemia B cells. Blood 1997;89:1732-1739.
52. Fais F, et al. Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells. J Clin Invest 1996;98:1659-1666.
53. Shimizu A, Nussenzweig MC, Han H, Sanchez M, Honjo T. Trans-splicing as a possible molecular mechanism for the multiple isotype expression of the immunoglobulin gene. J Exp Med 1991;173:1385-1393.
54. Vandenberghe E. Mantle cell lymphoma. Blood Rev 1994;8:79-87.
55. Du M-Q, Diss TC, Xu C-F, Wotherspoon AC, Isaacson PG, Pan L-X. Ongoing immunoglobulin gene mutations in mantle cell lymphomas. Br J Haematol 1997;96:124-131.
56. H genes with no or very little somatic mutations like the physiologic cells of the follicle mande. Blood 1994;84:403-407.
57. Kroemer G. The proto-oncongene Bcl-2 and its role in regulating apoptosis. Nat Med 1997;3:614-620.
58. Limpens J, et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 1995;85:2528-2536.
59. Han S, Zheng B, Schatz DG, Spanopoulou E, Kelsoe G. Neoteny in lymphocytes: Rag 1 and Rag 2 expression in germinal center B cells. Science 1996;274:2094-2097.
60. Srinivas SK, Sixbey JW. Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2. J Virol 1995;69:8155-8158.
61. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 1993;4:327-332.
62. Lo Coco F, et al. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 1994;83:1757-1759.
63. Onizuka T, et al. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood 1995;86:28-37.
64. H4 Ig gene family by diffuse large-cell lymphoma. Blood 1995;86:3072-3082.
65. Magrath I. Pathogenesis of Burkitt's lymphoma. Adv Cancer Res 1990;55:133-270.
66. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RW, Croce CM. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 1982;79:7824-7827.
67. Subar M, Neri A, Inghirami G, Knowles DM, Dalla-Favera R. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988;72:667-671.
68. Gregory CD, et al. Identification of a subset of normal B cells with a Burkitt's lymphoma-like phenotype. J Immunol 1987;139:313-318.
69. Wright DH. What is Burkitt's lymphoma? J Pathol 1997;182:125-127.
70. H genes used by neoplastic B cells in endemic Burkitt's lymphoma show somatic hypermutation and intraclonal heterogeneity. Blood 1995;85:2176-2181.
71. L gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection. Blood 1996;88:3562-3568.
72. Isaacson PG. Lymphomas of mucosa-associated lymphoid tissue (MALT). Histopathology 1990;16:617-619.
73. Wotherspoon AC, Ortiz-Hildago C, Falzon MF, Isaacson PG. Helicobacter pylori - associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-1176.
74. Du M-Q, et al. Intestinal dissemination of gastric mucosa-associated lymphoid tissue lymphoma. Blood 1996;88:4445-4451.
75. Schmid U, Helbron D, Lennert K. Development of malignant lymphoma in myoepithelial sialadenitis (Sjogren's syndrome). Virchows Arch (Pathol Anat) 1982;395:11-43.
76. Diss TC, Wotherspoon AC, Speight P, Pan L, Isaacson PG. B-cell monoclonality, Epstein-Barr virus and t(14;18) in myoepithelial sialadenitis and low grade B-cell MALT lymphoma of the parotid gland. Am J Surg Pathol 1955;19:531-536.
77. Ralph QM, Brisco MJ, Joshua DE, Brown R, Gibson J, Morley AA. Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: evidence from the Ig heavy chain gene. Blood 1993;82:202-206.
78. Wagner SD, Martinelli V, Luzzatto L. Similar patterns of Vκ gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenström's macroglobulinemia, and myeloma. Blood 1994;83:3647-3653.
79. H segments of Ig gene in Waldenström's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richters syndrome but not in common CLL. Blood 1995;85:1913-1919.
80. H gene analysis of clonally-related IgM and IgG from human lymphoplasmacytoid B-cell tumors with CLL features and high serum monoclonal IgG. Blood 1998;91:238-243.
81. Bakkus MHC, Heirman C, van Riet I, van Camp B, Thielemans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 1992;80:2326-2335.
82. Sahota S, Hamblin T, Oscier DG, Stevenson FK. Assessment of the role of clonogenic B lymphocytes in the pathogenesis of multiple myeloma. Leukemia 1994;8:1285-1289.
83. Vescio RA, et al. Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity. J Immunol 1995;155:2487-2497.
84. H gene sequences reveal a complementary imprint of antigen selection in tumor cells. Blood 1997;89:219-226.
85. H gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance. Blood 1996;87:746-755.
86. H gene sequence analysis of spontaneous murine Ig-secreting B-cell tumors with clinical features of human disease. Immunology (In press).
87. Corradini P, Boccadoro M, Voena C, Pileri A. Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to a Cμ sequence in (IgG)- and IgA- secreting multiple myelomas. J Exp Med 1993;178:1091-1096.
88. Billadeau D, Ahmann G, Greipp P, van Ness B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cells. J Exp Med 1993;178:1023-1031.
89. White MB, Word CJ, Humphries CG, Blattner FR, Tucker PW. Immunoglobulin D switching can occur through homologous recombination in human B cells. Mol Cell Biol 1990;10:3690-3699.
90. Juge-Morineau N, et al. Immunoglobulins D and M multiple myeloma variants are heavily mutated. Clin Cancer Res (In press).
91. Liu YJ, et al. Normal human IgD+IgM-germinal center B cells can express up to 80 mutations in the variable region of their IgD transcripts. Immunity 1996;4:603-613.
92. Braeuninger A, Küppers R, Strickler JG, Wacker H-H, Rajewsky K, Hansmann M-L. Hodgkin and Reed-Sternberg cells in lymphocytic predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci USA 1997;94:9337-9342.
93. Marafioti T, et al. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal center B cells. N Engl J Med 1997;337:453-458.
94. George AJT, Stevenson FK. Prospects for the treatment of B cell tumors using idiotypic vaccination. Int Rev Immunol 1989;4:271-310.
95. Hsu FJ, et al. Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma - long-term results of a clinical trial. Blood 1997;89:3129-3135.
96. Stevenson FK, Zhu D, King CA, Ashworth LJ, Kumar S, Hawkins RE. Idiotypic DNA vaccines against B-cell lymphoma. Immunol Rev 1995;145:211-228.
97. Syrengelas AD, Chen TT, Levy R. DNA immunization induces protective immunity against B cell lymphoma. Nat Med 1996;2:1038-1041.
98. Spellerberg MB, Zhu D, Thompsett A, King CA, Hamblin TJ, Stevenson FK. DNA vaccines against lymphoma. Promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to Tetanus Toxin Fragment C. J Immunol 1997;159:1885-1892.
99. Denépoux S, et al. Induction of somatic mutation in a human B cell line in vitro. Immunity 1997;6:35-16.
100. Razanajaona D, et al. In vitro triggering of somatic mutation in human naive B cells. J Immunol 1997;159:3347-3353.
101. Zhu D, Oscier DG, Stevenson FK. Splenic lymphoma with villous lymphocytes involves B cells with extensively mutated Ig heavy chain variable region genes. Blood 1995;85:1603-1607.